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Background: Host signals are being shown to have a major impact on the bacterial phenotype. One of them is the
endogenously produced catecholamine stress hormones, which are also used therapeutically as inotropes. Recent
work form our laboratories have found that stress hormones can markedly increase bacterial growth and virulence.
This report reveals that Streptococcus pneumoniae, a commensal that can also be a major cause of community
acquired and nosocomial pneumonia, is highly inotrope responsive. Therapeutic levels of the stress hormone
norepinephrine increased pneumococcal growth via a mechanism involving provision of iron from serum-
transferrin and inotrope uptake, as well as enhancing expression of key genes in central metabolism and virulence.
Collectively, our data suggests that Streptococcus pneumoniae recognises host stress as an environmental cue to
initiate growth and pathogenic processes.
Results: Effects of a clinically attainable concentration of norepinephrine on S. pneumoniae pathogenicity were
explored using in vitro growth and virulence assays, and RT-PCR gene expression profiling of genes involved in
metabolism and virulence.
We found that norepinephrine was a potent stimulator of growth, via a mechanism involving norepinephrine-delivery of
transferrin-iron and internalisation of the inotrope. Stress hormone exposure also markedly increased biofilm formation.
Importantly, gene profiling showed that norepinephrine significantly enhanced expression of genes involved in central
metabolism and host colonisation. Analysis of the response of the pneumococcal pspA and pspC mutants to the stress
hormone showed them to have a central involvement in the catecholamine response mechanism.
Conclusions: Collectively, our evidence suggests that the pneumococcus has mechanisms to recognise and process
host stress hormones to augment its virulence properties. The ability to respond to host stress signals may be
important for the pneumococcal transition from colonization to invasion mode, which is key to its capacity to
cause life-threatening pneumonia, septicaemia and meningitis.Background
Streptococcus pneumoniae is a major cause of otitis media,
meningitis, septicaemia and community and hospital ac-
quired pneumonia [1]. As well as being a potentially deadly
pathogen, the pneumococcus often resides in the human
nasopharynx without causing harm, a situation known as
carriage. Therefore two fundamental but so far un-
answered questions arise from consideration of pneumo-
coccal carriage and the range of diseases it causes. Which* Correspondence: ppef1@le.ac.uk; hy3@le.ac.uk
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unless otherwise stated.host signals trigger transition of the pneumococcus to a
pathogenic state, and how does the bacterium sense,
process and respond to these signals during the infection
in order to modulate its virulence in different tissue sites?
Increasing numbers of studies of infectious bacteria
are suggesting that the neuroendocrine (stress hormone)
status of a host may determine the outcome of an infec-
tion [2]. The recognition that stress hormone release
leads to increased risk of infection has come from the
finding that stress –associated chemicals negatively modu-
late immune function [3], and to their impact on the
growth and virulence of bacteria [2] Catecholamines have
been shown to augment the growth of species includingl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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nosa, Campylobacter jejuni and Bordetella bronchiseptica
[4]. The growth stimulating effect of catecholamines has
been largely related to the catechol-containing moiety
forming a complex with the iron within transferrin (Tf) or
lactoferrin (Lf), which weakens Fe binding and so enables
bacteria to acquire the normally inaccessible complexed-Fe
[5]. Catecholamines have also been shown to directly
modulate bacterial virulence. For instance, norepinephrine
(NE) stimulated the inflammatory and secretory responses
caused by E. coli O157:H7, and augmented the microbe’s
attachment to intestinal mucosa [6]. NE increased both the
cellular cytotoxicity and enterotoxicity of infection caused
by Vibrio parahaemolyticus and up-regulated the expres-
sion of type III secretion system-1 genes [7]. Catechol-
amine inotropes used in the treatment of acutely ill
patients (such as dopamine and epinephrine) also have
been shown to increase staphylococcal and pseudomonad
biofilm formation and promote recovery from antibiotic
damage [2,8,9].
Most of our knowledge on bacteria-catecholamine in-
teractions originated from the studies of Gram negative
gut pathogens, and comparatively little is known about
the interaction of Gram-positive bacteria with catechol-
amines [2,4]. In particular, the infection significance of
S. pneumoniae-catecholamine interactions is unclear in
spite of the demonstration of a significant increase in
plasma stress hormone level in patients with pneumococcal
pneumonia compared to healthy individuals [10]. Addition-
ally, in an experimental mouse model of pneumococcal
pneumonia it was shown that mice pre-exposed to stress
were more susceptible to pneumococcal infection [11]. Very
recently Marks et al. [12] used a tissue culture biofilm
model of infection combined with animal studies to
show that treatment of pneumococcal biofilms with a
variety of host factors such as ATP, glucose, NE and
cell lysates induced bacterial dispersal, and promoted
S. pneumoniae colonization of normally sterile host tis-
sues. Although this study showed that host chemicals
could influence the phenotype of S. pneumoniae, the
molecular mechanisms by which these behavioural
changes were induced were not determined. In this
study we show that therapeutic levels of NE can directly
affect the growth and virulence of S. pneumoniae and
identify the genes involved in host signal recognition.
Methods
Reagents
Human serum transferrin (Tf), ferric nitrate, and the
catecholamine norepinephrine were purchased from
Sigma Chemical Co. (Poole, Dorset. UK); 55FeCl3 (IES,
specific activity 5 mCi/mg Fe), 3H-NE (TRK584,l-[7,8-
3H] norepinephrine) were obtained from Amersham Life
Sciences, UK.Bacterial strains and growth conditions
S. pneumoniae type 4 strain TIGR4, and type 2 strain
D39 and its isogenic mutants were used in this work.
Routinely, for inoculum preparation pneumococci were
grown at 37°C in microaerophilic conditions either in
brain heart infusion broth (BHI), Todd-Hewitt Broth
(THB) (Oxoid, Basingstoke, UK) or on Blood Agar Base
(Oxoid) supplemented with 5% (v/v) horse blood. Where
appropriate the growth medium was supplemented with
100 μg/ml spectinomycin. In addition, to test catechol-
amine responsiveness of the pneumococci we used Sicard’s
defined medium supplemented with 50% (v/v) serum-SAPI
(a host-like serum-supplemented minimal medium) [2],
which we refer to in the text as serum-medium. To test
catecholamine responsive, bacteria were grown in the pres-
ence or absence of 10 μM NE (a concentration that
Thompson et al. had shown to occur in the human circula-
tion following inotrope administration) [13]. Bacteria were
inoculated at approximately 107 CFU/ml, and precise in-
oculum levels determined using pour plate counting [2].
All growth assays were carried out in at least tripli-
cate. To prepare passaged D39, mice infected intra-
peritoneally with 100 μl of overnight grown bacteria
in sterile PBS. When the signs of disease were ob-
served, blood was collected by cardiac puncture after
deep anaesthesia as described previously [14,15], and
10 ml BHI was inoculated with 50 μl blood. After
overnight growth, bacteria were recovered by centrifuga-
tion and then the pellet was used to inoculate 10 ml BHI
containing 20% (v/v) calf serum (Sigma). When the OD500
reached 1.6, growth was ceased and aliquots were kept
in −80°C until required.
Mutant construction
In vitro mariner mutagenesis was used to introduce mu-
tation to pspA as described previously [15,16]. Approxi-
mately 2 kb genomic region containing the target gene
was amplified with the appropriate primers (Table 1).
For transposition reactions 200 ng of PCR fragment was
mixed with 200–400 ng of donor mariner plasmid
pR412, which contains a spectinomycin resistance cas-
sette, and incubated in the presence of purified Himar1
transposase, as described previously [15,16]. Gaps in
transposition products were repaired with T4 DNA
polymerase (New England Biolabs, Ipswick, USA) and sub-
sequently by E. coli ligase (New England Biolabs). Repaired
transposition products were transformed into S. pneumo-
niae D39 using synthetic competence-inducing peptide [17].
Transformants isolated from selective medium were
tested for the presence of mariner mini-transposons
through PCR and sequencing [18], and then the purified
products were sequenced using MP127 primer. One of
the transformants designated as pspA−, was selected for
further study.
Table 1 Oligonucleotide primers used in this study


































MP 127 CCGGGGACTTATCAGCCAACC pR412 specific
MP 128 TACTAGCGACGCCATCTATGTG
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as described previously [19]. To create the pspA and
pspC double mutant, the mutated region in the pspA−
was PCR amplified with pspAF and pspAR primers, and
the amplified region transformed into pspC−. The muta-
tion was confirmed as described above, and one trans-
formant, designated pspAC−, was selected for further
study. PspA and PspC mutants constructed in the way
described above have been used in a number of different
studies [16,19,20].Quantitative RT-PCR
The extraction of RNA from catecholamine-treated and
control D39, pspA and pspC cultures (grown as de-
scribed in Methods) was carried out by the Trizol
method using mid-log phase cultures as described previ-
ously [21,22]. Before use the RNA was treated with amp-
lification grade DNase I (Qiagen, Crawley, UK) and
subsequently purified with an RNeasy Mini Kit (Qiagen).
First strand cDNA synthesis was performed on approxi-
mately 1 μg DNase-treated total RNA using 200 U of
SuperScript II reverse transcriptase (Invitrogen, Paisley,
UK), at 42°C for 55 min, and random hexamers [22].
The transcription level of specific genes was normalised
to gyrB transcription, and amplified in parallel with
SPD0709RTF and SP0709RTR primers. To reduce the
bias in qRT-PCR we used primer pairs with similar PCR
efficiencies. The results were analysed by the compara-
tive CT method, and a 2-fold difference in expression
relative to control was considered to be significant [22].
Pneumococcal transferrin binding assays
To analyse transferrin binding to the pneumococci, over-
night cultures grown as described in individual experi-
ments (approximately 109 CFU/ml) were harvested by
centrifugation at 10,000 g for 10 min, washed twice and
re-suspended in 1 ml of 100 mM Tris-SAPI pH7.5
[2,8,23]. Tf was added at 1 μg/ml; the negative control
consisted of addition of an equivalent volume of distilled
water. Test and control cultures were incubated at 37°C
for 1 hr, after which the bacteria were centrifuged at
10,000 g for 10 min, washed twice in PBS and re-suspended
in 100 μl of 100 mM Tris–HCl (pH 6.8) containing 10%
(v/v) glycerol, 2% (w/v) sodium dodecyl sulfate (SDS),
0.1% (w/v) bromophenol blue and 100 mM dithiothrei-
tol (DTT). This suspension was heated to 100°C for
15 min to release bound Tf. The cell free extracts were
then centrifuged at 10,000 g for 10 min, and the super-
natant electrophoresed on 10% SDS-polyacrylamide
gels, and electroblotted onto PVDF membranes. Blots
were probed with anti-Tf polyclonal antisera and cross-
recognition was determined using HRP-conjugated sec-
ondary antibodies and enhanced chemiluminescence as
described previously [23].
Pneumococcal transferrin iron uptake
To test the ability of S. pneumoniae to acquire iron from
Tf, serum-medium containing filter-sterilized 55Fe-Tf
(2 × 105 cpm ml−1) was supplemented with 10 μM NE
or an equivalent volume of water (control). Washed cul-
tures were added at 1 × 107 CFU/ml and incubated at
37°C in a 5% CO2 atmosphere for 24 hr. For analysis of
catecholamine internalisation, cultures were similarly
grown but supplemented with 1 × 105 cpm per ml of
3H-norepinephrine (control), with and without 10 μM
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tion at 10,000 g for 10 min, washed in PBS and assayed
for cell numbers and for radiolabel incorporation, using
scintillation counting as described previously [8,23].
Biofilm formation
Stress hormone effects on biofilm formation was analysed
microscopically and using the crystal violet attachment
assay [24]. Bacteria were cultured statically in serum-
medium in 150 μl volumes in triplicate in 96 well plates.
To ensure that growth levels of control and catecholamine-
treated cultures were the same, we inoculated cultures at a
higher level of 108 CFU/ml. After incubation, non-attached
bacteria and culture supernatants were removed and the
wells washed 3 times with PBS. The wells were then were
dried in hot air cabinet set at 50°C. After drying, crystal
violet (0.2% v/v) was added for 15 minutes. Then, wells
washed 3 times with PBS, tapped to remove residual li-
quid, and dried at room temperature. A mixture of
80% ethanol and 20% acetone was then added, and
measurement of attachment determined by absorbance
at 595 nm.
Quellung reaction and microscopy
Polysaccharide capsule was visualized by microscopic
examination of pneumococci after treatment with type-
specific antibody (Statens Serum Institute, Copenhagen)
as described previously [25]. Briefly, overnight cultures,
grown in serum-medium with or without NE, were smeared
onto a slide and air-dried. This was then covered with a
coverslip containing 10 μl of 1% (w/v) methylene blue and
10 μl type specific anti-capsular antibody (Statens Serum
Institute, Copenhagen, Denmark). The slide was exam-
ined by X1000 oil immersion microscopy.
Statistics
Growth analyses were performed in triplicate and all ex-
periments were performed on at least 3 separate occa-
sions; unless stated otherwise, numerical data shown are
expressed as mean +/− SD. Where appropriate, statis-
tical analysis was first performed using one-way ANOVA
and, if significant, an unpaired t-test. Statistical signifi-
cance was indicated by a P value of less than 0 · 05.
Results
Norepinephrine stimulates S. pneumoniae growth and
biofilm formation
Wildtype S. pneumoniae strain D39, routinely propa-
gated in vitro or its mouse passaged stock, and the
TIGR4 strain were inoculated into serum-medium (50%
Sicard [26] and 50% serum-SAPI, a host-like serum-
supplemented minimal medium); serum was included to
simulate in vivo conditions [2,8,23]. A time course of
growth in serum-medium in the presence and absenceof the catecholamine is shown in Figure 1, which reveals
that the cultures grew significantly better (P < 0.01) when
NE was present, indicating that all of the pneumococcal
strains were stress hormone responsive. The passaged
D39 showed overall greater growth levels (Figure 1C)
relative to non-passaged bacteria with or without NE.
Also, the decline in stationary phase optical density ob-
served in the inotrope supplemented culture of the
non-passaged D39 was not present in the NE-stimulated
passaged strain. In these experiments we used 10 μM NE,
a concentration which is attainable in vivo [13]. However,
dose responses analyses showed that lower levels of 5 μM
were equally stimulatory as 10 μM, which is a concentra-
tion attainable in vivo [13]. Interestingly, higher levels
such as 50 μM produced no greater increases in cell num-
bers than the 10 μM NE addition (data not shown). We
also found that the pneumococcus responds to other cat-
echolamine stress hormones, and that addition of 10 μM
dopamine or epinephrine were also stimulatory to growth
(Figure 1D and E).
The ability of infectious bacteria to attach to surfaces,
self-associate and form a biofilm is an aspect of viru-
lence that is particularly important in the development
of respiratory infections. It was found in the examination
of the NE-treated cultures that the peumococcus dis-
played a different morphology to the un-supplemented
control. Figure 1F is a light microscopy image of a quel-
lung reaction assay [25] which shows that for D39 rela-
tive to the control, NE had no obvious effect on capsule
formation, but did appear to reduce levels of cellular
debris suggesting an enhancing effect on cell viability.
What is also apparent in Figure 1F is the presence of NE
increased clumping (cell-cell association) of the bacteria,
which is an important intermediate stage in bacterial
biofilm formation. We therefore investigated the effects of
NE exposure on D39 attachment, the initial step in forma-
tion of a biofilm. Figure 1G shows over the course of a
3 day incubation in serum-medium that NE consistently
enhanced the attachment of the wildtype D39 (p < 0.05).
Very similar results were also found for strain TIGR4
(data not shown).
The mechanism of pneumococcal catecholamine growth
induction
We have shown that catecholamines can stimulate bac-
terial growth by enabling access to the iron within host
Fe binding proteins, such as transferrin [2,5,23,27]. Ino-
tropes achieve this by virtue of having a catechol moiety,
which can both bind and reduce ferric iron. This reduc-
tion to Fe(II) weakens the iron binding affinity of the
transferrin, allowing bacteria to then uptake the released
iron by either ferric or ferrous uptake systems [5]. Previ-
ous work has shown that S. pneumoniae can utilize fer-
ric and ferrous iron salts, and host Fe sources such as
Figure 1 NE stimulates pneumococcal growth and biofilm formation. Panels A-E show the time course of growth of wildtype S. pneumoniae
strain D39, TIGR4, and passaged D39 (D39-p) in serum-medium with (red line) and without (black line) the addition of 10 μM NE, epinephrine or
dopamine. Panel F is a microscope image showing how NE increased clumping (cell-cell association) of D39 relative to the control, and also
increased viability (shown by reduction in cellular lysis debris). Panel G shows the initial attachment of wildtype D39 after 24, 48 and 72 hrs
incubation in serum-medium +/−10 μM NE. Attachment was measured as described in Materials and Methods; key: black bar (control); grey
bar (NE); P < 0.05 for the collective values of all the NE vs. Control data points. Similar results were also seen with TIGR4 (data not shown).
For all experiments, n = 3.
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within Tf [28-30]. In terms of the growth stimulation
seen in Figure 1, Figure 2A reveals that Tf is bound by
S. pneumoniae in what appears to be a growth-phase
independent manner. Figure 2B shows that incubation
of the bacteria in serum-medium with Tf containing
radiolabelled Fe (55Fe-Tf ) allowed the pneumococcus
to obtain normally sequestered host Fe in higher amounts
if the stress hormone was present. We also investigated if
the NE was taken up by the pneumococcus during cat-
echolamine growth induction by including 3H-NE in the
serum-medium. Figure 2C shows that 3H-NE was interna-
lised, and that addition of non-labelled NE increased radi-




+ - + -
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Figure 2 Mechanism of norepinephrine growth induction. Panel
A is a western blot of Tf binding to D39 cultures (+) compared with
non-Tf supplemented control cultures (−); the influence of growth
phase on Tf binding is also shown: log-phase (L), stationary phase
(S). Tf represents purified transferrin and is the positive control,
indicated by the arrow. Panel B shows that uptake of Tf-complexed
Fe (in the form of 55Fe) is increased in the presence of NE, P < 0.05;
Panel C shows 3H-NE is internalised by D39. The values shown in
panels B and C are means of triplicate counts; n = 3.capacity of the NE to increase cell numbers. Mechanistic-
ally, this indicates that inotrope-mediated Fe delivery from
Tf and internalisation of the catecholamine are the prob-
able explanations for the growth induction in serum-
medium demonstrated by NE in Figure 1.
pspA and pspC are involved in pneumococcal
catecholamine inotrope responsiveness
The question that arose from the data in Figures 1 and 2
was what bacterial elements were involved in the mech-
anism by which NE facilitated growth increases in the
pneumococcus, and so the role of key pneumococcal
surface proteins, PspA and PspC, in the catecholamine
growth induction mechanism was investigated. These mu-
tants were chosen because previous studies had shown
the involvement of PspA and PspC in pneumococcal per-
sistence within the host, such as attachment, prevention
of complement deposition and factor H recognition
[19,20,31]. In addition PspA was shown to be important
for binding the host Fe protein lactoferrin [32]. Hence, we
constructed pspA, pspC, and pspA and pspC double mu-
tants in the D39 pneumococcal strain and analysed their
response to NE. Figures 3A-C show that in marked con-
trast to wildtype D39 (which is shown in Figure 2B), the
pspA and pspC mutants, singly or in combination, showed
no significant growth induction by the catecholamine.
To understand what the mechanism of this lack of re-
sponse might be, we compared the ability of the psp mu-
tants with wildtype D39 to acquire Fe from 55Fe-labelled
transferrin in the presence and absence of NE. Figure 3D-F
shows that in the absence of the catecholamine the psp
mutants were able to uptake some 55Fe-iron, but unlike
the parent strain (Figure 2B), were unable to utilise the NE
to obtain higher levels of the Tf-complexed 55Fe, with the
effect most strikingly seen in the double psp mutant which
was overall severely compromised in its ability to obtain Fe
from Tf (Figure 3F). We investigated if this was due to im-
paired binding of Tf, as PspA is a lactoferrin binding
protein [32]. We conducted similar experiments to those
used in Figure B for the pspA, pspC, and pspA and pspC
mutants, but to our surprise binding of Tf was no less
than that of the wildtype (data not shown).
We showed in Figure 2C that NE was internalised by
wildtype pneumococcus during the catecholamine growth
induction, and since the pspA and pspC appeared to be
non-NE responsive in the growth context, we also investi-
gated if these proteins were in some way involved in the
inotrope uptake. Figure 4 shows the internalisation of
radiolabelled 3H-NE by the single and double pspA and
pspC mutants, grown in serum-medium in the presence
and absence of added NE. For the pspA mutant, the pres-
ence of unlabelled NE stimulated uptake of the 3H-NE to
about 25% less than that shown by wildtype D39 (Figures 2C
and 4A). In contrast, inactivation of pspC resulted in 3H-NE
Figure 3 Role of the PspA and PspC in pneumococcal catecholamine responsiveness. Panels A-C show the time course of growth of pspA,
pspC and pspAC mutants in serum-medium in the absence (black line) or presence of 10 μM NE (red line). Panels D-F shows the pspA (pspA−),
pspC (pspC−) and pspAC (pspAC−) mutant uptake of Tf-complexed Fe (in the form of 55Fe) +/− NE; note that the wildtype D39 uptake of Tf-Fe in
the presence of NE is shown in Figure 2B. Values shown in panels D-F are means of triplicate counts; for all experiments, n = 3.
Sandrini et al. BMC Microbiology 2014, 14:180 Page 7 of 12
http://www.biomedcentral.com/1471-2180/14/180internalisation levels of >75% less than that of wildtype. The
pspA and pspC double mutant showed similar uptake levels
to the single pspC mutant. The data in Figures 3 and 4 col-
lectively shows that the PspA and PspC appear to be integral
elements in the mechanism by which NE induces S. pneu-
moniae growth in serum based medium.
Norepinephrine modulates pneumococcal metabolism
and virulence gene expression
We also examined in wildtype D39, and the pspA and pspC
single mutants the effects of NE exposure on the expres-
sion of 14 functionally diverse genes involved in pneumo-
coccal metabolism and virulence in order to identify genes
involved in stress hormone responsiveness of S. pneumo-
niae. In wildtype D39 the expression of 9 genes manifestedgreater than two-fold changes (Table 2), the commonly
agreed level of significance, although sometimes differences
of less than two-fold are known to be biologically import-
ant. The genes with increased expression included comX, a
response regulator for genetic competence, which is also
involved in biofilm formation [33], consistent with our
finding that NE increases pneumococcal attachment. Also
showing up regulation was the SPD_0939: Rgg family tran-
scriptional regulator, the members of which are in-
volved in oxidative stress response, biofilm formation,
quorum sensing and virulence [34,35]. In addition, dif-
ferential expression of genes involved in polysacchar-
ide degradation and sugar utilization (N-acetyl
hexosaminidase, β-galactosidase galactokinase and pyru-
vate oxidase) as well as iron transport, piuA, were observed
AB
C
Figure 4 Involvement of PspA and PspC in norepinephrine
uptake. Panels A-C show 3H-NE uptake pspA, pspC and pspAC
mutants after 24 hrs incubation in serum-medium as described in
Methods in the presence (grey) and absence of NE (black); P < 0.05.
Values shown are means of triplicate counts; for all experiments, n = 3.
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sugars are known to be low in the respiratory tract, forcing
the pneumococcus to rely on host glycoproteins such as
mucin, and the carbohydrates bound by host proteins such
as Tf to satisfy essential carbon needs [37]. Others and we
have demonstrated previously that glycosidases, such as
neuraminidases and galactosidases are highly important for
pneumococcal colonization and invasion [38].
We also show in Table 2 the catecholamine gene ex-
pression profiles of the pspA and pspC mutants. What is
striking is that mutating pspA and pspC appears to have
blocked NE-induced elevations in expression of many of
the genes which in wild type D39 showed a NE-inducedincrease. For instance, expression of the nanA and nanB
neuraminidases, which were up-regulated 22 and 10-
fold-fold by NE in wildtype D39, were un-induced in the
pspA and pspC mutants. Expression of the NE-responsive
transcriptional response regulator rgg/mutR, which showed
a 28-fold enhancement by NE in wildtype, was baseline in
both mutants, as was also the response regulator comX.
These results mirror strikingly the growth and NE uptake
profiles shown in Figure 2.
Discussion
Nasopharyngeal colonization is the first step of invasive
pneumococcal disease [1]. However, it is not known
what triggers the transition from colonization to inva-
siveness. Our on-going work on pneumococcal biology
indicates that environmental factors, such as changing
oxygen concentration, differences in metal and sugar
composition of tissues, can have a fundamental impact
on pneumococcal virulence [39,40]. However, although these
environmental factors are important, they do not explain
fully what triggers the sudden change from colonization to
invasiveness. Therefore, we investigated whether other host
factors, such as stress hormones, might be important for
transition of the pneumococcus from commensal to patho-
gen [2]. The reason for this hypothesis stems from the rapid
change in the concentration of stress hormones due to phys-
ical and emotional stress, from stress hormones’ adverse ef-
fect on immune system function [3], and from the microbial
ability to recognize and process human stress hormone
signals [2].
In this study we showed that S. pneumoniae responds to
levels of catecholamine found within the circulation of
inotrope-medicated patients [13] with increased growth and
virulence, which could have a major impact on the progres-
sion of pneumococcal infection or transmission to new
hosts. Many predisposing factors for pneumococcal diseases
including emotional and cold stress, and overcrowding are
known to increase stress hormone levels. In addition, cat-
echolamine inotropes are administered up to 50% of pa-
tients in intensive care unit (ICU) [41], and up to 56% of
patients with pneumococcal pneumonia are admitted to
ICU [41]. Hence, in addition to endogenously produced
stress hormones, pneumococci are exposed to externally
applied catecholamine inotropes. Growth stimulation
of S. pneumoniae came about due to the inotrope pro-
viding essential Fe for growth from the host iron bind-
ing protein transferrin, which was directly bound by
the bacteria. Interestingly, the supposedly simple in
function PspA and PspC surface proteins were found
to play a major role in NE mediated growth induction.
When the genes for PspA and PspC were mutated, the
ability of S. pneumoniae to utilize the additional Fe
provided from transferrin by the catecholamine was re-
duced. The uptake of the radiolabelled NE was
Table 2 S. pneumoniae gene expression in the presence of norepinephrine
Transcriptional
regulators
Function Fold change in expression
D39 pspA− pspC−
comX (SPD_0014) Transcriptional regulator ComX1 5.33 (0.15) 0.85 (0.03) 0.92 (0.09)
rgg (SPD_0144) Transcriptional regulator 1.72 (0.12) 0.40 (0.06) 1.13 (0.15)
ritR (SPD_0344) DNA-binding response regulator 0.77 (0.04) 0.73 (0.02) 0.97 (0.04)
rgg/mutR (SPD_0939) Transcriptional regulator 28.4 (2.2) 0.79 (0.06) 1.09 (0.13)
Sugar hydrolases
strH (SPD_0063) N-acetyl hexosaminidase 6.56 (0.30) 0.6 (0.02) 0.97 (0.04)
bga3 (SPD_0065) β-galactosidase 21.4 (2.0) 0.78 (0.04) 1.1 (0.05)
nanB (SPD_1499) Neuraminidase B 22.39 (1.10) 1.23 (0.12) 0.78 (0.08)
nanA (SPD_1504) Neuraminidase A 10.77 (0.89) 1.44 (0.07) 0.98 (0.04)
Cation metabolism
piuA (SPD_1652) Iron-compound ABC transporter 6.08 (0.20) 0.27 (0.03) 1.02 (0.03)
psaA (SPD_1463) ABC transporter substrate-binding protein 1.22 (0.04) 0.48 (0.03) 1.04 (0.03)
Sugar metabolism
pflB (SPD_0420) Pyruvate formate lyase 0.59 (0.03) 0.89 (0.02) 1.03 (0.06)
spxB (SPD_0722) Pyruvate oxidase 0.16 (0.07) 0.69 (0.03) 0.84 (0.12)
galK (SPD_1634) Galactokinase 25.36 (2.39) 0.78 (0.04) 0.92 (0.07)
Oxidative stress response
tpxD (SPD_1464) Thiolperoxidase 0.66 (0.07) 0.74 (0.06) 0.81 (0.1)
The relative gene expression levels of wildtype D39 and the pspA and pspC mutants was calculated from 3 independent experiments and standard deviation is
indicated in parenthesis. The expression of target genes was normalised to the housekeeping gene gyrB.
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peared to block NE-effects on gene expression, which
agrees well with the non-growth responsiveness ob-
served. Why PspA and PspC should be so important in
mediating catecholamine responsiveness in the
pneumococcus is unclear. The two proteins are im-
portant in virulence as they have been shown to play a
pivotal role in the inhibition of complement-mediated
opsonization [42,43], in prevention of lactoferrin killing [44],
and in facilitating the microbe’s attachment to the respiratory
tissues and the brain microvascular endothelium [19,30-32].
PspA is also known to bind to lactoferrin [32]. In addition,
PspA and PspC have been shown to elicit protective anti-
body response against invasive pneumococcal infection,
hence they are considered to be promising vaccine candi-
dates [31]. Although their contribution to S. pneumoniae-
host interaction is well studied, comparatively little is known
about their role in pneumococcal physiology. Previously,
using recombinant PspA and a strain mutated in pspA, it
was shown that PspA, but not PspC, is responsible for
pneumococcal binding to human lactoferrin, which was
suggested to be important to overcome the iron limita-
tion at mucosal surfaces [44,45]. Contrary to previous re-
ports [32,45], in this study we consistently demonstrated
that S. pneumoniae could bind to transferrin, and acquire
iron from this glycoprotein, and that uptake of Fe from Tfwas enhanced when NE was present. The reason for this
discrepancy could be due to different culture conditions,
and detection technology used for transferrin binding. For
example, unlike Hakansson et al., (2001) [45] we used a
serum based medium to prepare pneumococcal cultures,
which can affect the synthesis of proteins involved in
binding to Tf. Currently, the mechanism of PspA and
PspC mediated pneumococcal response to NE is not
known and so defining how PspA and PspC are mediating
catecholamine responsiveness is a current focus of our la-
boratories. However, based on the available data it is clear
that these surface proteins are required for recognition
and/or internalisation of NE since the mutation of pspA
or pspC abolished NE responsiveness, reduced NE uptake
and blocked catecholamine-induced gene responsiveness.
This clearly indicates that the proteins encoded by these
genes may be acting as a sensor molecule. It is not surpris-
ing that both PspA and PspC are involved in stress hor-
mone mediated effects in S. pneumoniae given these
proteins are coded by paralogous genes, and previous
studies have demonstrated their involvement in similar
biological events [31,42,43]. In future experiments, we
plan to investigate to which downstream targets PspA and
PspC relay NE mediated messages.
A recent study by Marks et al. [12] showed that NE
treatment of biofilms formed in vitro, and in vivo in the
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the dispersed cells display distinct phenotypic traits that
are different from those of both biofilm and broth-
grown planktonic bacteria. The dispersed pneumococci
were shown to have differential virulence gene expres-
sion, and had a significantly increased ability to dissem-
inate and cause infection in the middle ear, lungs, and
bloodstream. Our results are consistent with Marks et al.,
[12] in that the pneumococcus responds to NE, and that
treatment with the catecholamine leads to differential
gene expression. On the other hand, contrary to the
Marks et al. study, who used biotic surfaces to determine
NE’s role in pneumococcal dispersion from biofilms, our
results show that in host like serum-containing media the
catecholamine aggregates the pneumococci and promotes
biofilm formation on abiotic surfaces. The reason for this
seeming discrepancy could be due to methodological dif-
ferences and also be attributed to NE’s possible dual func-
tion in biofilm formation. In other words, NE can initially
promote bacterial biofilm formation (our current study)
and after a certain stage in the infection process, depend-
ing on the microbial growth phase, may also promote dis-
persion of the pneumococci [12]. Interestingly, a recent
paper from Gonzales et al. [46] found that addition of a
non-therapeutic level of NE (100 μM) stimulated several-
fold increases in growth but in contrast to our data, had
an inhibitory effect on pneumococcal biofilm formation,
as measured by attachment to host cells. Therefore, it is
clear that further work is required to understand this dif-
ferential effect of the catecholamine on biofilm formation.
In this study NE mediated Fe uptake from Tf was
identified as the mechanism responsible for the observed
growth effect of NE in serum based media. However, our
gene expression analysis in wild type D39 shows that NE
has an even wider effect on pneumococcal physiology.
For example, the expression of genes coding for glycosi-
dases (nanA, nanB, bgaC and strH), which are responsible
for deglycosylation of host glycans and play important role
in pneumococcal colonization and invasiveness [36,37],
were significantly upregulated in the presence of NE.
Moreover, differential expression of genes involved in
transcriptional regulation (SPD_0939), competence devel-
opment (comX), galactose metabolism (galK), and iron
transport (piuA) was also detected, indicating the compre-
hensive effect of NE on pneumococcal metabolism. Cur-
rently it is not known how the pneumococcus detects and
processes stress hormone signals, though there is a clear
involvement of PspA and PspC in the response mechan-
ism. Therefore, investigating the underlying genetic mech-
anisms for detection and processing of catecholamine
signals is a priority. Also, in this study we found that the
pneumococcus responds similarly to a variety of catechol-
amine stress hormones (NE, as well as dopamine and epi-
nephrine), which is in contrast to the situation demonstratedin Mycoplasma hypopneumoniae [47]. This finding is also of
clinical significance as 300 μM epinephrine may be adminis-
tered directly to ventilated patients to reduce airway inflam-
mation [8].
Bacteria have evolved mechanisms to sense the changes
in the stress hormone levels using receptors, which appear
to be specific and able to differentiate between different
stress hormones [2,4,48]. Using α and β receptor antago-
nists, we showed the presence of putative adrenergic and
dopaminergic receptors in three Gram-negative bacteria:
Escherichia coli, Salmonella enterica and Yersinia enteroco-
litica [49]. Our results demonstrated that catecholamine-
induced growth in these bacteria could be blocked by
catecholamine α-receptor antagonists, but not by an-
tagonists for β adrenergic receptors. But, so far, no
comprehensive study has been conducted to investi-
gate proteins responsible for stress hormone recogni-
tion in Gram positive bacteria. Identification of such
receptors in the pneumococcus would enhance our un-
derstanding of S. pneumoniae-host interactions and may
offer alternative therapeutic options against pneumococcal
diseases.
Conclusions
A clinically attainable level of NE stimulated pneumococ-
cal growth via a mechanism involving inotrope-delivery of
transferrin-iron and internalisation of the inotrope. NE
also markedly increased S. pneumoniae-biofilm formation.
Gene profiling showed that norepinephrine significantly
enhanced expression of genes involved in central metabol-
ism and host colonisation. Analysis of the response of the
pneumoccal pspA and pspC mutants to the stress hor-
mone showed them to have a central involvement in the
catecholamine response mechanism. Collectively, our
results suggest that inotrope-pneumococcal interactions
may be a contributory factor for the development of
S. pneumoniae-associated pneumonia.
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